-transparent.png){kind=logo}
Ninety-eight patients with diabetes mellitus (52 women and 46 men) underwent a glucagon stimulated C-peptide test. Treatment was instigated on the basis of classical criteria, independent of the test results, and remained unchanged during a 2-yr test period. The type of treatment and metabolic control were then related to the test results. Fasting C-peptide concentrations do not discriminate between insulin dependent and non-insulin dependent diabetes mellitus. C-peptide concentrations 10 min after intravenous injection of 1 mg of glucagon, however, correctly classified the patients. With the help of this test, the correct model of treatment for patients with diabetes mellitus can be chosen.
T Vahlkamp, and
A Lütjens, and
E H Nauta
May 1992,
Journal of the Formosan Medical Association = Taiwan yi zhi,
T Vahlkamp, and
A Lütjens, and
E H Nauta
December 2015,
Medical & biological engineering & computing,
T Vahlkamp, and
A Lütjens, and
E H Nauta
January 1984,
Duodecim; laaketieteellinen aikakauskirja,
T Vahlkamp, and
A Lütjens, and
E H Nauta
January 1996,
Journal of veterinary internal medicine,
T Vahlkamp, and
A Lütjens, and
E H Nauta
July 1977,
Diabetes,
T Vahlkamp, and
A Lütjens, and
E H Nauta
January 1994,
Diabetes research (Edinburgh, Scotland),
T Vahlkamp, and
A Lütjens, and
E H Nauta
March 2016,
Medical & biological engineering & computing,
T Vahlkamp, and
A Lütjens, and
E H Nauta
June 2000,
The West Indian medical journal,
T Vahlkamp, and
A Lütjens, and
E H Nauta
April 2001,
The Journal of clinical endocrinology and metabolism,
T Vahlkamp, and
A Lütjens, and
E H Nauta
May 1989,
Diabetologia,
